Atlas Trials

Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients

Clinical trial NCT01639599 · COMPLETED

Trial details

NCT number
NCT01639599
Sponsor
The Catholic University of Korea
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Gynecological Disease
Start date
2012-03-01
Primary completion
2012-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.